secwatch.observer — SEC 8-K summary
======================================

Issuer:     MACROGENICS INC (MGNX)
CIK:        0001125345
Form:       8-K
Filed at:   2022-12-21T23:59:59+00:00
Accession:  0001125345-22-000113
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MacroGenics appoints Margaret Liu, M.D. to Board of Directors effective Jan 3, 2023
--------------------------------------------------------------------------------

- Dr. Liu will serve as a Class II director until the 2024 Annual Meeting or until successor is elected.
- She has been appointed to the Science & Technology Committee, effective January 3, 2023.
- Initial grant of option to purchase 36,000 shares vesting monthly over 36 months from grant date.
- Annual retainer and compensation per the Company's Director Compensation Program as disclosed in April 2022 proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1125345/000112534522000113/0001125345-22-000113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1125345/000112534522000113/mgnx-20221219.htm
  HTML page:      https://secwatch.observer/filing/0001125345-22-000113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer